Transformation of an Interleukin 3-Dependent Hematopoietic Cell Line by the Chronic Myelogenous Leukemia-Specific P210bcr/abl Protein by Daley, George Q. & Baltimore, David
Proc. Natl. Acad. Sci. USA
Vol. 85, pp. 9312-9316, December 1988
Medical Sciences
Transformation of an interleukin 3-dependent hematopoietic
cell line by the chronic myelogenous leukemia-specific
P21Obcr/abl protein
(Abelson murine leukemia virus/Philadelphia chromosome/tyrosine kinase)
GEORGE Q. DALEY AND DAVID BALTIMORE
Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142; and Department of Biology, Massachusetts Institute of Technology,
Cambridge, MA 02139
Contributed by David Baltimore, September 6, 1988
ABSTRACT The P210bcr/a'M protein is associated with
virtually every case of human chronic myelogenous leukemia.
Unlike the related P160m/v'bI oncogene product of Abelson
murine leukemia virus, p210ler/abl does not transform NIH 3T3
fibroblasts. To assess whether P210b"/abl might transform
hematopoietic cell types, retroviral constructs encoding
P2101/abI were used to infect the bone marrow-derived
interleukin 3-dependent Ba/F3 cell line. As for P160mg/v-'bI,
cell lines expressing P210bcO/abl were growth factor independent
and tumorigenic in nude mice. No evidence for autocrine
production of interleukin 3 by factor-independent cell lines was
found. These experiments establish that P21014/au can trans-
form hematopoietic cell types to tumorigenicity.
The p210bcr/abl protein derives from a hybrid gene created by
the chromosomal translocation that generates the Philadel-
phia chromosome, a cytogenetic abnormality which charac-
terizes human chronic myelogenous leukemia (CML) cells
(1). The CML-specific P210 protein shares structural and
enzymatic properties with the v-abl protein of the Abelson
murine leukemia virus (A-MuLV). The gene for P210 and
v-abl arose by substitution of the c-abl* sequence encoding
the N-terminal region with bcr (2) and helper-virus-derived
gag sequences (3), respectively. Both proteins exhibit ele-
vated tyrosine-specific protein kinase activity (4). The v-abl
protein is responsible for the induction of acute lymphosar-
comas in susceptible murine hosts infected with A-MuLV (5).
The role of P210 in the etiology ofhuman CML remains to be
defined.
The v-abl protein can transform a variety of cell types. It
efficiently transforms NIH 3T3 fibroblasts in vitro (6) and
pre-B-lymphoid cells both in vitro and in vivo (7) and is able
to relieve the growth-factor dependence of several hemato-
poietic cell types, including T-cell lines dependent on inter-
leukin 2 (8), and various interleukin 3 (IL-3)-dependent
lymphoid and myeloid cell lines (9-13). Unlike v-abl, P210
does not transform NIH 3T3 fibroblasts (14). In this study, we
demonstrate that P210 resembles v-abl in its ability to
transform the IL-3-dependent hematopoietic cell line Ba/F3
(15) to factor independence and tumorigenicity. These ex-
periments demonstrate the oncogenic potential of P210br/abl.
MATERIALS AND METHODS
Plasmid Constructs, Viral Stocks, and Cell Culture Condi-
tions. A 4.7-kilobase (kb) fragment containing coding se-
quence for the full-length P160 isolate ofv-abl (16) was cloned
into the BamHI cloning site of the pWE vector (B. Guild and
R. C. Mulligan, Whitehead Institute) by using BamHI link-
ers. The resulting size for the pWEgab construct was 8.7 kb
from the 5' long terminal repeat (LTR) to the 3' LTR. The
full-length P210b~r/abl cDNA 172/215 (17) was cloned into
pWE by using Bcl I linkers. The resulting LTR-LTR size for
the pWE210 construct was 11 kb. Viral stocks were gener-
ated by the following methods. Replication-competent ret-
roviral complexes were made by cotransfection of the con-
structs with helper Moloney murine leukemia virus DNA
(pZAP, ref. 18) onto NIH 3T3 cells. Alternatively, helper-free
retroviral stocks were made by transfecting the constructs
onto the packaging line qi-2 (19) and infecting tunicamycin-
treated q-2 cells with a transient viral harvest from the
transfected qi-2 cells. Retroviral supernatants from G418-
resistant producer populations were harvested after 18 hr and
passed through a 0.45-,um filter. Viral supernatants were
titered for G418 resistance by infection of NIH 3T3 fibro-
blasts. All retroviral producer cell lines had comparable titers
in the range of 105 G418-resistant colony-forming units/ml.
Ba/F3 is a murine bone marrow-derived cell line depen-
dent on IL-3 for viability and proliferation (15). Ba/F3 cells
are classified as early cells of the lymphoblastoid lineage by
virtue oftheir low-level expression ofthe B-cell-specific B220
antigen (unpublished data) and the germ-line configuration of
their immunoglobulin loci. Ba/F3 cells were maintained in
standard RPMI 1640 medium supplemented with 10%
(vol/vol) fetal calf serum and 10% (vol/vol) conditioned
medium from the WEHI-3B cell line (as a source of IL-3, ref.
20). Ba/F3 cells are able to grow in medium supplemented
with fetal calf serum and purified recombinant IL-3 alone
(unpublished data). Ba/F3 cells not only fail to proliferate but
also rapidly die in the absence of an exogenous source of
IL-3. Numerous experiments with the Ba/F3 cell line con-
ducted in this laboratory have failed to generate any spon-
taneous IL-3-independent clones. Ba/F3 cells (2 x 106 cells)
were infected by incubation with 2 ml of viral supernatant and
Polybrene at 8 ,ug/ml for 2 hr or by a 48-hr cocultivation with
helper-free packaging lines in the presence of Polybrene at 2
,ug/ml. Infected Ba/F3 cells were maintained in the presence
ofWEHI-3B conditioned medium for 48 hr and then selected
for retroviral infection in G418 at 2 mg/ml. G418-resistant
populations were washed twice with isotonic phosphate-
buffered saline (PBS) before plating in medium lacking a
source of IL-3 to select for IL-3-independent growth.
Assay of Cell Proliferation. Cell proliferation was assessed
by an adaptation of the tetrazolium dye reduction assay of
Mosmann (21). Relevant Ba/F3 cell lines were washed twice
with PBS and resuspended at 5 x 105 cells per ml in RPMI
medium containing 5% (vol/vol) fetal calf serum. Cells were
Abbreviations: CML, chronic myelogenous leukemia; A-MuLV,
Abelson murine leukemia virus; IL-3, interleukin 3; LTR, long
terminal repeat.
*In this report, lowercase italic gene symbols will be used for all
genes, regardless of species of origin.
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dispensed in triplicate into 96-well plates (2.5 x 104 cells per
well). Test supernatants were added in appropriate dilution to
the plates, which were incubated for 24 hr at 370C. 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(Sigma) was added to each well, and the cells were further
incubated for 5 hr. The absorbance was measured on a
Dynatech model MR580 plate reader at a wavelength of 570
nm. A neutralizing polyclonal anti-IL-3 IgG was a gift from
P. Vassalli (University of Geneva), and a control polyclonal
IgG specific for the epidermal growth factor receptor was a
gift of Y. Yarden (Whitehead Institute). IgG was preincu-
bated with conditioned medium for 1 hr prior to addition to
the proliferation assay.
Nucleic Acid and Protein Analysis. High molecular weight
genomic DNA was isolated from relevant cell lines, digested
with the enzyme Xba I, electrophoresed through a 0.7%
agarose gel, transferred to a nylon membrane, and probed
with a fragment of the G418-resistance (Neo) gene labeled to
high specific activity (>109 cpm/Ag). Hybridization and
wash conditions were of high stringency. Immunoprecipita-
tion analysis of abl proteins was as described (22).
Assay of Tumorigenicity in Nude Mice. Cells for assay of
tumorigenicity were washed with serum-free medium and
resuspended in Hanks' balanced saline solution. About 2 x
106 cells were injected subcutaneously into young (<12 week
old) nude mice (BALB/c-AnNCr-nu) from the National
Cancer Institute. Mice received 500 rads (1 rad = 0.001 Gy)
of y-irradiation 24 hr prior to cell challenge. Mice were
observed for 2-3 months for signs ofpalpable or visible tumor
at the site of injection. Tumorigenic cell lines gave rise to a
visible pea-sized mass with a short latency after injection
which was nonregressing and malignant. Nontumorigenic
cell lines showed no evidence of tumor for up to 3 months
after injection.
RESULTS
Constructs for expression of abl protein variants were made
by using the pWE vector (Fig. 1). The pWE vector carries a
dominant coselectable antibiotic-resistance marker ex-
pressed from the promoter element of the Moloney virus
LTR. The cloned abl sequence is expressed from an internal
promoter derived from the chicken p-actin gene. Titers of
retroviral producer cell supernatants were determined by
resistance of infected NIH 3T3 fibroblasts to the antibiotic
G418 and were comparable for all constructs (105 colony-
forming units/ml). IL-3-dependent Ba/F3 cells were infected
with retroviral-producer cell culture supernatants and grown
for 48 hr in the presence of WEHI-3B conditioned medium
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prior to selection (Fig. 2). Primary selection for viral infection
was carried out in medium supplemented with both WEHI-
3B conditioned medium and G418 at 2 mg/ml. For all infected
cell lines, G418-resistant populations arose after 7-10 days of
selection, suggesting that -0.1% of cells had been infected.
To select for IL-3 independence, G418-resistant populations
were washed extensively with PBS and cultured in medium
lacking a source of IL-3. Cell populations infected with the
pWE210 virus (encoding p210bcr/abl) or the pWEgab virus
(encoding P1605ag/V-abl) gave rise to populations of IL-
3-independent cells after 5-10 days, suggesting that between
0.1% and 5% of cells survived selection. A G418-resistant
population of cells infected with the pWE virus alone or
uninfected cells did not survive selection in medium lacking
a source of IL-3, demonstrating that abl sequences are
required to generate IL-3 independence (Table 1).
Uninfected Ba/F3 cells proliferate maximally in the pres-
ence of3-1o (vol/vol) conditioned medium from WEHI-3B
cells, and their proliferation declines upon dilution of the
conditioned medium (Fig. 3). The proliferation profile for
Ba/F3 cells infected with the pWE virus alone is similar to
that for the uninfected Ba/F3 cell line (Fig. 3A). Cells
infected with viruses that encode P21Obcr/ab, or p16gag/v-ab1
and selected for growth in the absence of exogenous IL-3
proliferate in a factor-independent manner, without regard to
the concentration of conditioned medium from WEHI-3B
cells. Their growth rate is equivalent to the parental Ba/F3
cell line growing in medium supplemented with IL-3 (unpub-
lished data). Conditioned medium from the IL-3-independent
cell lines infected with either the pWE210 or pWEgab viruses
will not support the proliferation of uninfected Ba/F3 cells.
This suggests that the pWE210- and pWEgab-infected cells
do not liberate a growth factor into the medium that can
support their growth by autocrine stimulation. Analysis of
total RNA from the IL-3-independent cell lines failed to
detect expression of IL-3 mRNA, although it could readily be
detected in WEHI-3B cells (unpublished data). Fig. 3B shows
the results of experiments with a specific antibody to IL-3
capable of neutralizing its growth-promoting activity. IgG
directed at an irrelevant antigen (the epidermal growth factor
receptor) failed to alter the proliferation profile for uninfected
Ba/F3 cells. IgG specific for IL-3 inhibited the proliferative
activity of WEHI-3B conditioned medium for uninfected
Ba/F3 cells. The IL-3-independent Ba/F3 cells infected with
either the pWE210 or pWEgab viruses were assayed in
medium lacking WEHI-3B conditioned medium in the pres-
ence of neutralizing anti-IL-3 IgG. The proliferation of the
pWE210- and pWEgab-infected cells was unaffected by the
presence of the neutralizing IgG.
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FIG. 1. Retroviral constructs. The pWE vector is a derivative ofthe Moloney murine leukemia virus (B. Guild and R. C. Mulligan, Whitehead
Institute). The Neo gene, encoding resistance to the antibiotic G418, is expressed from the 5' LTR. An internal promoter from the chicken /3-actin
gene directs the expression of cloned cDNA inserted into the unique BamHI cloning site. SV and pBR represent sequences for the simian virus
40 and pBR322 plasmid origins of replication. For pWE210, the cDNA for the full-length coding region ofthe p210bcr/abl protein (cDNA 172/215,
ref. 14) was cloned into the pWE vector by using Bcl I linkers. For pWEgab, sequences encoding the P160m/v-abl isolate of A-MuLV (16) were
cloned into the pWE vector by using BamHI linkers.
Medical Sciences: Daley and Baltimore
9314 Medical Sciences: Daley and Baltimore
VIRUS
RETROVIRAL
PRODUCERS I
IL-3 dependent
BaF3 cells
Primary selection
in G418 medium
G418 resistant population
Secondary selection
in medium lacking IL-3
IL-3 independent population
I Tumorigenicity
Rescue virus
FIG. 2. Strategy for generation and analysis of IL-3-independent
Ba/F3 cell lines. Retroviral producer cell lines were generated.
Ba/F3 cells were maintained in RPMI 1640 medium supplemented
with 10% (vol/vol) heat-inactivated fetal calf serum and 10o (vol/
vol) conditioned medium from WEHI-3B cells (a source of IL-3, ref.
20). Approximately 2 x 106 Ba/F3 cells were incubated with
retroviral supernatant for 2 hr in the presence of Polybrene at 8
,g/ml. Alternatively, cells were infected by a 48-hr cocultivation
with helper-free retroviral producer cell lines in the presence of
Polybrene at 2 ,ug/ml. Infected cells were grown for 48 hr before
primary selection for retroviral integration in medium containing
G418 at 2 mg/ml. G418-resistant populations of cells were washed
twice with PBS before secondary selection for IL-3 independence in
medium lacking a source of IL-3. Virus was rescued from IL-
3-independent cell lines by superinfection with helper Moloney virus.
Analysis of the proviral structure in the IL-3-independent
cell lines showed the pWE210 and pWEgab viruses to be
intact and unrearranged. Digestion of total genomic DNA
with the restriction endonuclease Xba I, which cuts within
the retroviral LTRs to expose the full-length provirus, dem-
onstrated the expected fragment sizes for the relevant con-
structs (Fig. 4). The correct proviral structure was detected
by either the G418-resistance (Neo) gene or c-abl probe
sequences (unpublished data). The provirus in these cell lines
was rescued by superinfection with Moloney helper virus.
Virus rescued from either pWE210- or pWEgab-infected
IL-3-independent cell lines passed the G418-resistance
marker upon infection of NIH 3T3 cells, but only virus
rescued from pWEgab-infected cell lines was able to trans-
form NIH 3T3 cells (Table 1). The properties of the rescued
virus match those of the original viral stock used to effect the
IL-3-independent phenotype for Ba/F3 cells.
Cell extracts of relevant cell lines were immunoprecipita-
ted with anti-abl antisera (23) and processed for the immune-
complex kinase reaction with [y-32P]ATP. The precipitated
proteins were displayed by NaDodSO4/polyacrylamide gel
electrophoresis and visualized by autoradiography (Fig. 5).
Cell lines infected with the pWE210 and pWEgab viruses and
selected in G418 expressed the P210bcr/abl and p160gag/v-abl
proteins, respectively. IL-3-independent cell populations
invariably expressed higher levels of abl protein, suggesting
that IL-3 independence requires high-level expression of abl
protein.
IL-3-independent cell lines expressing P210bcr/abl and
p160gag/v-abl (either with helper virus or helper-free) were
assayed for their tumorigenicity in nude mice. The parental
Ba/F3 cells, or Ba/F3 cells infected with the pWE virus
alone, did not form tumors upon subcutaneous challenge.
The IL-3-independent, pWE210-infected, and pWEgab-
infected cells readily formed tumors at the site of subcuta-
neous injection that were of short latency, nonregressing, and
ultimately lethal to the host (Table 1).
DISCUSSION
A common denominator in CML is the Philadelphia chro-
mosome, a t(9;22) that is detectable in a high proportion
(>90%) of patients (24). The Philadelphia translocationjuxtaposes c-abl protooncogene sequences on chromosome 9
with a locus on chromosome 22 (bcr) that encodes a protein
ofunknown function (25). The ability to detect the molecular
rearrangement of bcr and abl in a proportion of the CML
patients for whom cytogenetic evidence of the Philadelphia
chromosome is lacking (26) further strengthens the associa-
tion of the aberrant chromosome with the disease. The
product of the Philadelphia chromosome, the P210bcr/abl
fusion protein, resembles the P160sag/v-abl oncogene product
in enzymatic and structural properties. The c-abl sequences
that are deleted in the formation of P210 and P160 v-abl share
homology with nonreceptor tyrosine kinases (e.g., src and
fps), phospholipase C, and the avian v-crk oncogene (27, 28).
Simple deletion of this region within the c-abl type IV
sequence is sufficient to activate the transforming potential of
c-abl for fibroblasts and lymphoid cells (P. Jackson and D.B.,
unpublished results). The association of the Philadelphia
Table 1. Properties of infected Ba/F3 cells
Growth of Ba/F3 cells Ability of
in selective medium conditioned Properties of
after viral infection Tumors medium to rescued virus
Primary, Secondary, in nude support Ba/F3 Passes Neo Transforms 3T3
Virus Protein + IL-3/ + G418 - IL-3/ + G418 mice cell proliferation gene cells
Mock 0/8
pWE + - 0/7
pWEgab p16ogam/v-abl + + 9/9 - + +
pWE210 p210bcr/abl + + 12/12 - +
For the capacity to establish Ba/F3 cell line under conditions of primary selection (G418 resistance) or secondary selection (IL-3
independence), + indicates establishment ofcontinuously proliferating cell line and - indicates cell line will not grow under specified conditions.
To establish whether infected cells could produce tumors in nude mice, the number of mice that developed large, nonregressing tumors at the
site of subcutaneous injection of cells over the number of mice challenged is shown. To determine whether conditioned medium could support
Ba/F3 cell proliferation, conditioned medium was harvested from helper-virus-free cell lines at high density and passed through a 0.45-,pm filter.
-, Cells could not proliferate. To establish properties ofrescued virus, Ba/F3 cell lines were superinfected with helper Moloney murine leukemia
virus. Rescued retroviral supernatant was passed through a 0.45-.um filter before infection of NIH 3T3 cells. Infected cells were assayed for
passage of the G418-resistance (Neo) gene by selection in G418 at 1 mg/ml or were allowed to grow to confluence and examined for the
appearance of foci of transformed cells. +, Virus has indicated property; -, virus lacks the property.
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FIG. 3. Proliferation assay of Ba/F3 cell lines. Effect of dilution
of conditioned medium on proliferation of various Ba/F3 cell lines.
Conditioned medium is from the WEHI-3B cell line, a source of IL-3,
unless otherwise noted. (A) *, Uninfected cells; o, pWE-infected
cells; *, pWEgab-infected cells; o, pWE210-infected cells; A, unin-
fected Ba/F3 cells plus conditioned medium from pWE210-infected
Ba/F3 cells; A, uninfected Ba/F3 cells plus conditioned medium
from pWEgab-infected Ba/F3 cells. (B) *, Uninfected cells; o,
uninfected cells assayed in presence of 10 pAg of control IgG
(anti-epidermal growth factor receptor antibody); A, uninfected cells
assayed in 3% (vol/vol) WEHI-3B conditioned medium to dilution of
a neutralizing anti-IL-3 IgG; *, pWEgab-infected cells assayed in
medium lacking IL-3 to the indicated dilution of neutralizing anti-
IL-3 IgG; o, pWE210-infected cells assayed in medium lacking IL-3
to the indicated dilution of neutralizing anti-IL-3 IgG. Anti-IL-3 IgG
(10 ,ug) neutralized 100o of the proliferative activity of 3 ,ul of
WEHI-3B conditioned medium for Ba/F3 cells. Proliferation mea-
surements have been normalized by subtracting the optical density
(570 nm) for nonproliferating cells from each assay point and dividing
by the optical density of maximally proliferating cells.
chromosome with virtually every case of CML and the
similarity of P210bcr/abl to the v-abl oncogene product of the
Abelson murine leukemia virus strongly implicates P210 in
the pathogenesis of CML.
A previous study demonstrated the growth-promoting
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FIG. 4. Proviral structure in infected G418-resistant Ba/F3 cell
lines. Genomic DNA (2 dig) isolated from relevant cell lines was
digested with the enzyme Xba I to demonstrate full-length provirus.
Hybridization with a probe derived from the G418-resistance (Neo)
gene occurred under conditions of high stringency. Lanes: 1,
pWE-infected Ba/F3 cells maintained in medium supplemented with
IL-3; 2, pWE210-infected cells maintained in medium supplemented
with IL-3 prior to selection for IL-3 independence; 3 and 4,
pWE21O-infected cell lines selected for IL-3-independent growth in
medium lacking IL-3; 5, pWEgab-infected cells maintained in me-
dium supplemented with IL-3; 6 and 7, pWEgab-infected cell lines
selected for IL-3-independent growth.
effects of P210 on early cells of the B-lymphoid lineage in the
Whitlock-Witte bone marrow culture system (29). Not all of
the clonal lines stimulated by P210 in that system were
tumorigenic. Reminiscent of disease progression from
chronic to acute phase, some clones progressed to tumori-
genicity upon passage in culture, suggesting that secondary
events were necessary in acquiring the full-tumorigenic
phenotype. Whereas that study involved infection ofprimary
bone marrow, the Ba/F3 cell line used in these experiments
has been adapted for continuous growth in culture and may
be more permissive for transformation.
This study demonstrates that the gene for P21Obcr/abl can
function as a dominant oncogene. Like v-abl, it will trans-
form the bone-marrow-derived IL-3-dependent Ba/F3 cell
line to factor independence and tumorigenicity. P210 does not
trigger the endogenous expression of IL-3 or other growth
factors capable of stimulating Ba/F3 proliferation in an
autocrine manner. The proliferation of the P210-transformed
cells in the presence of a neutralizing anti-IL-3 antibody
argues that the cells are not hyperresponsive to undetectable
levels of IL-3 present in the growth medium. Rather,
P2lObcr/abl must itself provide the stimulus for Ba/F3 cell
proliferation normally provided through the IL-3 signal
transduction pathway.
These experiments establish the oncogenic potential of
P210bcr/abl for the lymphoblastoid cell line Ba/F3. Prelimi-
nary results suggest that P210 will transform the IL-
3-dependent mast cell line 32Dc13 to factor independence,
thus demonstrating transformation for myeloid cell types
(unpublished data). Unlike v-abl, P210 cannot transform NIH
3T3 fibroblasts unless it recombines with N-terminal gag
sequences from the helper virus, which provides a myristoy-
lation function critical for fibroblast transformation (14).
Given that P210 will not transform fibroblasts, the require-
ments for transformation of adherent and nonadherent cell
types by abl proteins appear to be distinct.
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FIG. 5. Immunoprecipitation analysis of infected Ba/F3 cell
lines. Cell extracts were incubated with anti-abl antisera (pEX4/5
mixture, ref. 23) and processed for in vitro immune-complex kinase
reaction as described (22). Proteins were displayed by NaDodSO4/
polyacrylamide gel electrophoresis and visualized by autoradiogra-
phy. Each lane was normalized for total protein content. Lanes: 1,
pWE210-infected cells maintained in IL-3 prior to selection for IL-3
independence; 2, pWE210-infected cells selected for IL-3-
independent growth; 3, pWEgab-infected cells maintained in IL-3
prior to selection for IL-3 independence; 4, pWEgab-infected cells
selected for IL-3-independent growth.
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